SAM
RVMD icon

Sectoral Asset Management’s Revolution Medicines RVMD Stock Holding History

Sectoral Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$343K Hold
1,830
– – 0.24% 69
2026
Q1 		$202K Buy
+1,830
New +$185K 0.17% 76
2025
Q3 		– Sell
-6,240
Closed -$230K – 91
2025
Q2 		$230K Hold
6,240
– – 0.15% 83
2025
Q1 		$221K Buy
6,240
+1,340
+27% +$54.4K 0.17% 69
2024
Q4 		$214K Sell
4,900
-1,530
-24% -$77.2K 0.14% 74
2024
Q3 		$292K Sell
6,430
-170
-3% -$7.4K 0.17% 78
2024
Q2 		$256K Sell
6,600
-6,310
-49% -$236K 0.1% 85
2024
Q1 		$416K Sell
12,910
-800
-6% -$23.7K 0.16% 77
2023
Q4 		$393K Sell
13,710
-128,940
-90% -$3.1M 0.17% 85
2023
Q3 		$3.95M Buy
+142,650
New +$4.23M 0.77% 57
2021
Q1 		– Sell
-389,006
Closed -$15.4M – 128
2020
Q4 		$15.4M Sell
389,006
-244,084
-39% -$9.65M 1.09% 35
2020
Q3 		$22M Buy
+633,090
New +$17.5M 1.89% 18

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Sectoral Asset Management's RVMD Position: Q2 2026 in Review

Sectoral Asset Management held its Revolution Medicines (RVMD) position steady in Q2 2026 at 1,830 shares worth $343K. The position accounts for 0.24% of the portfolio, ranked #69.

Sectoral Asset Management first reported a position in RVMD in Q3 2020 and has held it in 12 quarters since. The position peaked at $22M in Q3 2020. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Sectoral Asset Management held 1,830 shares of Revolution Medicines worth $343K as of Q2 2026.
  • Sectoral Asset Management left its Revolution Medicines share count unchanged in Q2 2026.
  • Revolution Medicines made up 0.24% of Sectoral Asset Management's portfolio in Q2 2026, its #69 holding.
  • Sectoral Asset Management first reported a position in Revolution Medicines in Q3 2020 and has held it in 12 quarters since.
  • Sectoral Asset Management's Revolution Medicines position peaked at $22M in Q3 2020.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Sectoral Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.